The article focuses on asthma and the treatment that could alleviate the condition. The statistics show that the number of Americans influenced by the condition is more than 22 million. Respiratory problems change the life of every person, affecting its quality and the fact that close to 4000 people die from asthma is very concerning for the modern age. A new treatment called “Alair Bronchial Thermoplasty System” was approved by the U. S. Food and Drug Administration and will be the next step to the way asthma patients are being treated. It is directed to treat very bad and complicated conditions for patients who are eighteen and older.
The procedure is centered on the placement of catheter through the airways, either nose or mouth. Most of asthma patients are used to having an inhaler with them and this way, there is not much new technology, except the chemicals of the medicine itself. The patient can also choose the amount of sedation between moderate and deep.
The results showed a 32% decrease in the need for further medical involvement—systemic steroids. 84% less visits to the emergency room with respiratory problems were recorded. 73% less cases of hospitalization with respiratory problems. And 66% gain of lost time because of asthma attacks. There was an increase by 2.5 times in the days where the symptoms of asthma were not experienced. The rescue medication was used 45% fewer times. Their return and follow up examination in the patients and their usage of the treatment has shown steady data supported by much evidence.
The medication has shown to be very reliable and effective. All the symptoms, as well as recurring states have been decreased. The treatment has made the condition stable over time and was proved as an effective alternative to several other medications.